Page 210 - HIV/AIDS Guidelines
P. 210

Table 16a. Interactions Among Protease Inhibitors*

            *NFV and IDV are not included in this table. Please refer to NFV and IDV FDA package inserts for information regarding NFV and IDV drug
             interactions.

            Drug
                         ATV              FPV             LPV/r            RTV             SQV            TPV
           Affected
          DRV       Dose: ATV 300 mg  No data       Should not be    Dose: (DRV 600 mg  Should not be  No data
                    once daily + DRV                coadministered   + RTV 100 mg) BID  coadministered
                    600 mg BID + RTV                because doses are  or (DRV 800 mg +  because doses
                    100 mg BID                      not established  RTV 100 mg) once  are not
                                                                     daily            established

          FPV       Dose: Insufficient              Should not be    Dose: (FPV 1400  Dose: Insufficient  Should not be
                    data                            coadministered   mg + RTV 100 mg  data            coadministered
                                                    because doses are  or                             because doses
                                           •
                                                    not established  200 mg) once daily;              are not
                                                                     or (FPV 700 mg +                 established
                                                                     RTV 100 mg) BID
          LPV/r     Dose: ATV 300 mg  Should not be                  LPV is           Dose: SQV 1000  Should not be
                    once daily + LPV/r  coadministered               coformulated with  mg BID + LPV/r  coadministered
                    400/100 mg BID  because doses are       •        RTV as Kaletra.  400/100 mg BID  because doses
                                    not established                                                   are not
                                                                                                      established
          RTV       Dose: (ATV 300 mg Dose: (FPV 1400  LPV is                         Dose: (SQV 1000  Dose: (TPV 500
                    + RTV 100 mg)   mg + RTV 100 mg  coformulated with                mg + RTV 100 mg)  mg + RTV 200
                    once daily      or 200 mg) once  RTV and marketed       •         BID             mg) BID
                                    daily; or (FPV 700  as Kaletra.
                                    mg + RTV 100 mg)
                                    BID
          SQV       Dose: Insufficient  Dose: Insufficient  Dose: SQV 1000  Dose: (SQV 1000           Should not be
                    data            data            mg BID + LPV/r   mg + RTV 100 mg)                 coadministered
                                                    400/100 mg BID   BID                     •        because doses
                                                                                                      are not
                                                                                                      established

            Key to Abbreviations: ATV = atazanavir, BID = twice daily, DRV = darunavir, FDA = Food and Drug Administration, FPV = fosamprenavir,
            IDV = indinavir, LPV/r = lopinavir/ritonavir, NFV = nelfinavir, PI = protease inhibitor, RTV = ritonavir, SQV = saquinavir, TPV = tipranavir






























            Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents        K-40

                            Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
   205   206   207   208   209   210   211   212   213   214   215